» Articles » PMID: 37845283

Recurrent DNMT3B Rearrangements Are Associated with Unfavorable Outcome in Dicentric (9;20)-positive Pediatric BCP-ALL

Citing Articles

The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis.

Lenk L, Baccelli I, Laqua A, Heymann J, Reimer C, Dietterle A Blood. 2024; 143(26):2735-2748.

PMID: 38518105 PMC: 11251409. DOI: 10.1182/blood.2023021088.

References
1.
Clark R, Byatt S, Bennett C, Brama M, Martineau M, Moorman A . Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia. 2000; 14(2):241-6. DOI: 10.1038/sj.leu.2401654. View

2.
Forestier E, Gauffin F, Andersen M, Autio K, Borgstrom G, Golovleva I . Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer. 2007; 47(2):149-58. DOI: 10.1002/gcc.20517. View

3.
Zachariadis V, Gauffin F, Kuchinskaya E, Heyman M, Schoumans J, Blennow E . The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial. Leukemia. 2011; 25(4):622-8. DOI: 10.1038/leu.2010.318. View

4.
An Q, Wright S, Moorman A, Parker H, Griffiths M, Ross F . Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21. Haematologica. 2009; 94(8):1164-9. PMC: 2719040. DOI: 10.3324/haematol.2008.002808. View

5.
Schoumans J, Johansson B, Corcoran M, Kuchinskaya E, Golovleva I, Grander D . Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol. 2006; 135(4):492-9. DOI: 10.1111/j.1365-2141.2006.06328.x. View